Your browser doesn't support javascript.
loading
Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements.
Johnson, Kara A; Dosenbach, Nico U F; Gordon, Evan M; Welle, Cristin G; Wilkins, Kevin B; Bronte-Stewart, Helen M; Voon, Valerie; Morishita, Takashi; Sakai, Yuki; Merner, Amanda R; Lázaro-Muñoz, Gabriel; Williamson, Theresa; Horn, Andreas; Gilron, Ro'ee; O'Keeffe, Jonathan; Gittis, Aryn H; Neumann, Wolf-Julian; Little, Simon; Provenza, Nicole R; Sheth, Sameer A; Fasano, Alfonso; Holt-Becker, Abbey B; Raike, Robert S; Moore, Lisa; Pathak, Yagna J; Greene, David; Marceglia, Sara; Krinke, Lothar; Tan, Huiling; Bergman, Hagai; Pötter-Nerger, Monika; Sun, Bomin; Cabrera, Laura Y; McIntyre, Cameron C; Harel, Noam; Mayberg, Helen S; Krystal, Andrew D; Pouratian, Nader; Starr, Philip A; Foote, Kelly D; Okun, Michael S; Wong, Joshua K.
Afiliación
  • Johnson KA; Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL, United States.
  • Dosenbach NUF; Department of Neurology, University of Florida, Gainesville, FL, United States.
  • Gordon EM; Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
  • Welle CG; Department of Radiology, Washington University School of Medicine, St. Louis, MO, United States.
  • Wilkins KB; Department of Physiology and Biophysics, University of Colorado School of Medicine, Aurora, CO, United States.
  • Bronte-Stewart HM; Department of Neurosurgery, University of Colorado School of Medicine, Aurora, CO, United States.
  • Voon V; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.
  • Morishita T; Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, United States.
  • Sakai Y; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Merner AR; Department of Neurosurgery, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
  • Lázaro-Muñoz G; ATR Brain Information Communication Research Laboratory Group, Kyoto, Japan.
  • Williamson T; Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Horn A; Center for Bioethics, Harvard Medical School, Boston, MA, United States.
  • Gilron R; Center for Bioethics, Harvard Medical School, Boston, MA, United States.
  • O'Keeffe J; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
  • Gittis AH; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, United States.
  • Neumann WJ; Department of Neurology, Center for Brain Circuit Therapeutics, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, United States.
  • Little S; MGH Neurosurgery and Center for Neurotechnology and Neurorecovery (CNTR) at MGH Neurology Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Provenza NR; Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany.
  • Sheth SA; Rune Labs, San Francisco, CA, United States.
  • Fasano A; Machine Medicine, London, United Kingdom.
  • Holt-Becker AB; Biological Sciences and Center for Neural Basis of Cognition, Carnegie Mellon University, Pittsburgh, PA, United States.
  • Raike RS; Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany.
  • Moore L; Department of Neurological Surgery, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.
  • Pathak YJ; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, United States.
  • Greene D; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, United States.
  • Marceglia S; Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network (UHN), University of Toronto, Toronto, ON, Canada.
  • Krinke L; Krembil Brain Institute, Toronto, ON, Canada.
  • Tan H; Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc., Minneapolis, MN, United States.
  • Bergman H; Restorative Therapies Group Implantables, Research, and Core Technology, Medtronic Inc., Minneapolis, MN, United States.
  • Pötter-Nerger M; Boston Scientific Neuromodulation Corporation, Valencia, CA, United States.
  • Sun B; Neuromodulation Division, Abbott, Plano, TX, United States.
  • Cabrera LY; NeuroPace, Inc., Mountain View, CA, United States.
  • McIntyre CC; Department of Engineering and Architecture, University of Trieste, Trieste, Italy.
  • Harel N; Newronika SPA, Milan, Italy.
  • Mayberg HS; Department of Neuroscience, West Virginia University, Morgantown, WV, United States.
  • Krystal AD; Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Pouratian N; Edmond and Lily Safar Center (ELSC) for Brain Research and Department of Medical Neurobiology (Physiology), Institute of Medical Research Israel-Canada, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Starr PA; Department of Neurosurgery, Hadassah Medical Center, Jerusalem, Israel.
  • Foote KD; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Okun MS; Department of Neurosurgery, Center for Functional Neurosurgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wong JK; Neuroethics, Department of Engineering Science and Mechanics, Philosophy, and Bioethics, and the Rock Ethics Institute, Pennsylvania State University, State College, PA, United States.
Front Hum Neurosci ; 18: 1320806, 2024.
Article en En | MEDLINE | ID: mdl-38450221
ABSTRACT
The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9-11, 2023 in Gainesville, Florida with the theme of "Pushing the Forefront of Neuromodulation". The keynote speaker was Dr. Nico Dosenbach from Washington University in St. Louis, Missouri. He presented his research recently published in Nature inn a collaboration with Dr. Evan Gordon to identify and characterize the somato-cognitive action network (SCAN), which has redefined the motor homunculus and has led to new hypotheses about the integrative networks underpinning therapeutic DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers, and researchers (from industry and academia) can freely discuss current and emerging DBS technologies, as well as logistical and ethical issues facing the field. The group estimated that globally more than 263,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year's meeting was focused on advances in the following areas cutting-edge translational neuromodulation, cutting-edge physiology, advances in neuromodulation from Europe and Asia, neuroethical dilemmas, artificial intelligence and computational modeling, time scales in DBS for mood disorders, and advances in future neuromodulation devices.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Hum Neurosci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Hum Neurosci Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos